WHITE PAPER
Outperform by 30% with Next Best
How Artificial Intelligence is Revolutionizing Decision-Making in Commercial
Feb 08, 2022

In a post-COVID-19 world, HCP expectations have changed, and a new engagement paradigm has emerged. Once a predominantly push-based model, today’s digital evolution has shifted HCP engagement to a hybrid push-and-pull-based model across a diverse ecosystem of channels and stakeholders.

Commercial teams at pharma companies are turning to artificial intelligence to identify just-in-time actions that meet the precise needs of HCPs. Armed with deep insight into their preferences, digital and social patterns, and the right tools, teams are delivering highly relevant, personalized, and differentiating HCP journeys through flexible, predefined algorithms and analytics-driven recommendations embedded within workflows.

This white paper outlines how commercial teams are leveraging intelligence to:
  • Adapt to market shifts and the changing expectations of HCPs
  • Deliver greater value through personalization and intelligent orchestration
  • Improve decision-making through embedded intelligence
  • Scale AI innovation across global markets and brands

Related solutions

Contact Us